 | • レポートコード：TPM-C02148 • 出版社/出版日：Transparency Market Research / 2018年11月19日 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：Healthcare |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ヘマトクリット試験装置の世界市場について調べ、ヘマトクリット試験装置の世界規模、市場動向、市場環境、製品別（血液分析装置、ヘマトクリットテストメーター）分析、エンドユーザー別（病院および外来手術センター、診療所、診断および病理検査室）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・ヘマトクリット試験装置の世界市場動向 ・ヘマトクリット試験装置の世界市場環境 ・ヘマトクリット試験装置の世界市場規模 ・ヘマトクリット試験装置の世界市場規模：製品別（血液分析装置、ヘマトクリットテストメーター） ・ヘマトクリット試験装置の世界市場規模：エンドユーザー別（病院および外来手術センター、診療所、診断および病理検査室） ・ヘマトクリット試験装置の世界市場：地域別市場規模・分析 ・ヘマトクリット試験装置の北米市場規模・予測 ・ヘマトクリット試験装置のアメリカ市場規模・予測 ・ヘマトクリット試験装置の中南米市場規模・予測 ・ヘマトクリット試験装置のヨーロッパ市場規模・予測 ・ヘマトクリット試験装置のアジア市場規模・予測 ・ヘマトクリット試験装置の日本市場規模・予測 ・ヘマトクリット試験装置の中国市場規模・予測 ・ヘマトクリット試験装置のインド市場規模・予測 ・ヘマトクリット試験装置の中東市場規模・予測 ・ヘマトクリット試験装置のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Hematocrit Test Devices Market – Overview
This report studies the current as well as future prospects of the global hematocrit test devices market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of hematocrit test devices and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study. The section also provides information and data analysis of the global hematocrit test devices market in terms of product, end-user, and region.
The global hematocrit test devices market has been segmented based on product, end-user and region. In terms of product, the global market has been classified into blood analyzers, hematocrit test meter, and others. The others segment comprises reagents and accessories. Based on end-user, the global hematocrit test devices market has been segmented into hospitals & ambulatory surgical centers, clinics, diagnostic & pathology labs, and others. The hospitals & ambulatory surgical centers segment is expected to dominate the global hematocrit test devices market during the forecast period.
Bottom-up approach has been employed for determining the size of the global hematocrit test devices market, using various market indicators obtained from secondary sources, which include analysis of launched products and mapping of sale of hematocrit test devices of top market players in specific regions. Top-down approach has been used to derive the market size of different product segments, wherein revenue of all publicly listed market players was obtained through secondary sources and analyzed for sales by narrowing down to revenue percentage for product segment through extensive analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on both secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. Market size and forecast, in terms of US$ Mn, for each segment has been provided for the period from 2016 to 2026. The report also provides compound annual growth rate (CAGR) in percentage for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.
The overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have significant impact on the global hematocrit test devices market and may influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition in the market across regions. Competitive scenario existing among the market players has been evaluated through market share analysis in the competitive landscape section of the report. These analyses are likely to help market players take strategic decisions to strengthen their positions and grow their share in the global hematocrit test devices market. The report also comprises major mergers & acquisitions, reimbursement scenario by region/global market, epidemiological overview of blood related disease diseases, and key launches & approvals.
In terms of region, the global hematocrit test devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries in the above mentioned regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and growth opportunities has been provided in the overview section. Competitive landscape section of the report provides analysis of market share of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global drug eluting balloon market.
Major players operating in the global hematocrit test devices market are Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers, EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott Laboratories, HORIBA, Ltd., and Boule Diagnostics.
The global hematocrit test devices market has been segmented as follows:
Global Hematocrit Test Devices Market, by Product
Blood Analyzers
Hematocrit Test Meters
Others
Global Hematocrit Test Devices Market, by End-user
Hospitals & Ambulatory Surgical Centers
Clinics
Diagnostic & Pathology Labs
Others
Global Hematocrit Test Devices Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hematocrit Test Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5. Market Outlook
5.1.Prevalence of Anemia among pregnant women by key countries
5.2. Prevalence of Anemia by global and WHO region
5.3. Key Mergers & Acquisitions
5.4.Recent Product Launches and Approval
5.5.Comparative Analysis of Hematocrit Test Method
5.6.Epidemiological Overview of blood related Disease
6. Global Hematocrit Test Devices Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2016–2026
6.3.1. Blood Analyzers
6.3.2. Hematocrit Test Meters
6.3.3. Others
6.4. Market Attractiveness, by Product
7. Global Hematocrit Test Devices Market Analysis and Forecasts, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2016–2026
7.3.1. Hospitals & Ambulatory Surgical Centers
7.3.2. Clinics
7.3.3. Diagnostic & Pathology Labs
7.3.4. Others
7.4. Market Attractiveness, by End-user
8. Global Hematocrit Test Devices Market Analysis and Forecasts, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Hematocrit Test Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2016–2026
9.2.1. Blood Analyzers
9.2.2. Hematocrit Test Meters
9.2.3. Others
9.3. Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals & Ambulatory Surgical Centers
9.3.2. Clinics
9.3.3. Diagnostic & Pathology Labs
9.3.4. Others
9.4. Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Hematocrit Test Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016–2026
10.2.1. Blood Analyzers
10.2.2. Hematocrit Test Meters
10.2.3. Others
10.3. Market Value Forecast, by End-user, 2016–2026
10.3.1. Hospitals & Ambulatory Surgical Centers
10.3.2. Clinics
10.3.3. Diagnostic & Pathology Labs
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Hematocrit Test Devices Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product, 2016–2026
11.2.1. Blood Analyzers
11.2.2. Hematocrit Test Meters
11.2.3. Others
11.3.Market Value Forecast, by End-user, 2016–2026
11.3.1. Hospitals & Ambulatory Surgical Centers
11.3.2. Clinics
11.3.3. Diagnostic & Pathology Labs
11.3.4. Others
11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5.Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Hematocrit Test Devices Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product, 2016–2026
12.2.1. Blood Analyzers
12.2.2. Hematocrit Test Meters
12.2.3. Others
12.3.Market Value Forecast, by End-user, 2016–2026
12.3.1. Hospitals & Ambulatory Surgical Centers
12.3.2. Clinics
12.3.3. Diagnostic & Pathology Labs
12.3.4. Others
12.4.Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5.Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Hematocrit Test Devices Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product, 2016–2026
13.2.1. Blood Analyzers
13.2.2. Hematocrit Test Meters
13.2.3. Others
13.3.Market Value Forecast, by End-user, 2016–2026
13.3.1. Hospitals & Ambulatory Surgical Centers
13.3.2. Clinics
13.3.3. Diagnostic & Pathology Labs
13.3.4. Others
13.4.Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Israel
13.4.4. Rest of Middle East & Africa
13.5.Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1.Market Player – Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis, by Company (2016)
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. NIHON KOHDEN CORPORATION
14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.1.2. Product Portfolio
14.4.1.3. SWOT Analysis
14.4.1.4. Strategic Overview
14.4.1.5. Financial Overview
14.4.2. F. Hoffmann-La Roche Ltd
14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2.2. Product Portfolio
14.4.2.3. SWOT Analysis
14.4.2.4. Strategic Overview
14.4.2.5. Financial Overview
14.4.3. Danaher Corporation
14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.3.2. Product Portfolio
14.4.3.3. SWOT Analysis
14.4.3.4. Strategic Overview
14.4.3.5. Financial Overview
14.4.4. Siemens Healthineers (Siemens AG)
14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.4.2. Product Portfolio
14.4.4.3. SWOT Analysis
14.4.4.4. Strategic Overview
14.4.4.5. Financial Overview
14.4.5. EKF Diagnostics Holdings plc
14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.5.2. Product Portfolio
14.4.5.3. SWOT Analysis
14.4.5.4. Strategic Overview
14.4.5.5. Financial Overview
14.4.6. Sysmex Corporation
14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.6.2. Product Portfolio
14.4.6.3. SWOT Analysis
14.4.6.4. Strategic Overview
14.4.6.5. Financial Overview
14.4.7. Nova Biomedical
14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.7.2. Product Portfolio
14.4.7.3. SWOT Analysis
14.4.7.4. Strategic Overview
14.4.7.5. Financial Overview
14.4.8. Abbott Laboratories
14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.8.2. Product Portfolio
14.4.8.3. SWOT Analysis
14.4.8.4. Strategic Overview
14.4.8.5. Financial Overview
14.4.9. HORIBA, Ltd.
14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.9.2. Product Portfolio
14.4.9.3. SWOT Analysis
14.4.9.4. Strategic Overview
14.4.9.5. Financial Overview
14.4.10. Boule Diagnostics
14.4.6.10. Company Overview (HQ, Business Segments, Employee Strength)
14.4.10.2. Product Portfolio
14.4.10.3. SWOT Analysis
14.4.10.4. Strategic Overview
14.4.10.5. Financial Overview
15. Competition Landscape
List of TablesTable 1: Prevalence of Anemia among Pregnant Women, by Key Countries
Table 2: Prevalence of anemia among children aged 6-59 months according to Global and WHO region
Table 3: Prevalence of Anemia among all women of reproductive age (15-49) years according to Global and WHO region
Table 4: Comparative Analysis of Hematocrit Test Methods
Table 5: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016-2026
Table 6: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
Table 7: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Region, 2016-2026
Table 8: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 9: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 10: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 15: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 16: Asia Pacific Hematocrit Test Devices Market value (US$ Mn) Forecast, by End-user, 2016?2026
Table 17: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 18: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 19: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016?2026
Table 20: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-regions, 2016–2026
Table 21: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026